But the non-invasive scores (AST/ALT ratio, APRI score, FIB-4 index, BARD score, NAFLD-fibrosis score) lack the required specificity and accuracy. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.